hsa-miR-135a-3p
Submitted by Anonymous on Wed, 10/30/2019 - 22:16
Pubmed
| Gene symble | Title | PMID | Curated descirption | Category | Literature category |
|---|---|---|---|---|---|
| hsa-miR-135a-3p | MicroRNA-135a-3p as a promising biomarker and nucleic acid therapeutic agent for ovarian cancer | 28231414 | MiR-135a-3p may be considered as a biomarker and a therapeutic agent in ovarian cancer | biomarker | BC/OC research |
| hsa-miR-135a-3p | miR-135a inhibits tumor metastasis and angiogenesis by targeting FAK pathway | 28415713 | MiR-135a is a novel downstream gene of tumor suppressor p53;the expression and function of miR-135a in gastric cancer and uncovers a novel regulatory mechanism of miR-135a | mechanism | BC/OC research |
| hsa-miR-135a-3p | MicroRNA-135a-3p is downregulated and serves as a tumour suppressor in ovarian cancer by targeting CCR2 | 30138893 | MiR-135a-3p serves as a tumour suppressor gene in ovarian cancer by regulating CCR2 | mechanism | BC/OC research |
| hsa-miR-135a-3p | miR-135a-3p as a promising biomarker and nucleic acid therapeutic agent for ovarian cancer | Link | MiR-135a-3p expression could be used as a noninvasive biomarker in serum of patients with ovarian carcinoma in the diagnosis and follow-up of the disease | biomarker | BC/OC research |
Survival analysis
Pathways
| Enriched Terms | Cross Refer. |
|---|---|
| Prion diseases | KEGG |
| Antigen processing and presentation | KEGG |
| Allograft rejection | KEGG |